ArticleJournal of clinical neurology (Seoul, Korea)2023
Neuropsychological Comparison of Patients With Alzheimer's Disease and Dementia With Lewy Bodies.
Article in Journal of clinical neurology (Seoul, Korea), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Cerebral perfusion correlates of domain-specific cognitive function in Alzheimer's disease and dementia with Lewy bodies.Journal of Alzheimer's disease : JAD · 2026Article
- Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies.Neurology · 2026Article
- Longitudinal resting-state EEG-based modeling predicts phenoconversion and delineates heterogeneity in isolated REM sleep behavior disorder.Research square · 2026Article
- Cognitive tests distinguish biomarker-verified early Alzheimer's disease from other patients.BMC neurology · 2026Article
- Beyond Single Biomarkers: Toward Integrated Staging in Alzheimer's Disease.Journal of clinical neurology (Seoul, Korea) · 2025Article
- Patients with dementia with Lewy bodies display a signature alteration of their cognitive connectome.Scientific reports · 2025Article
- Delineation of the cognitive and neuropsychiatric features of Pisa syndrome in dementia with Lewy bodies.Frontiers in aging neuroscience · 2025Article
- Alteration of medial temporal lobe metabolism related to Alzheimer's disease and dementia with lewy bodies.Alzheimer's research & therapy · 2024Article
- Re: Comments on "Neuropsychological Comparison of Patients With Alzheimer's Disease and Dementia With Lewy Bodies": Author Response.Journal of clinical neurology (Seoul, Korea) · 2023Article
- Comment on "Neuropsychological Comparison of Patients With Alzheimer's Disease and Dementia With Lewy Bodies".Journal of clinical neurology (Seoul, Korea) · 2023Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
background and purposeThis study aimed to determine the neuropsychological differences between patients with early-stage Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) with a Clinical Dementia Rating (CDR) score of ≤1.
methodsWe examined 168 patients with AD (126 with CDR score=0.5, 42 with CDR score=1) and 169 patients with DLB (104 with CDR score=0.5, 65 with CDR score=1) whose diagnoses were supported by
resultsAt CDR scores of both 0.5 and 1, the DLB group had lower scores on the attention (digit-span forward at CDR score=0.5 and backward at CDR score=1), visuospatial, and executive (color reading Stroop test at CDR score=0.5 and phonemic fluency test, Stroop tests, and digit symbol coding at CDR score=1) tests than the AD group, but higher scores on the memory tests. The AD
conclusionsPatients with DLB had worse attention, visuospatial, and executive functions but better memory function than patients with AD. Parkinsonism was not uncommon in the patients with AD and could be related to attention and executive dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.